Sucrose Breath Test to Determine Intestinal Permeability in IBS
The Use of a Novel 13C Sucrose Breath Test (13C SBT) to Determine Intestinal Permeability in Irritable Bowel Syndrome (IBS) Patients
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610
- University of Florida Shands Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male or females with clinical diagnosis of Irritable Bowel Syndrome by Rome III criteria (IBS Group) or healthy control.
- Must be 18 years old or greater.
- Women of child-bearing potential must have a negative pregnancy test.
Exclusion Criteria:
- Females who are lactating or pregnant.
- Subjects with allergy to sucrose.
- Subjects with other causes of abdominal pain or altered bowel habits such as IBD, celiac disease, pancreatitis or gastrointestinal bleeding.
- Subjects with a history of diabetes mellitus.
- Subjects with a recent febrile illness (5 days prior to study).
- Subjects that received an investigational drug or device within 30 days prior to study entry.
- Subjects that do not have the mental capacity to understand the protocol.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Irritable Bowel Syndrome
Subjects meeting Rome III criteria will be included as the group Irritable Bowel Syndrome
|
|
Healthy Controls
Subjects not meeting Rome III criteria and meeting clinical definitions of general good health will be considered as Healthy Controls
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Area under the breath 13CO2 concentration versus time curve (AUC) of sucrose
Time Frame: 90 minutes
|
AUC curves will be generated after measurement of breath carbon-13 labeled carbon dioxide over 90 minutes of collection.
|
90 minutes
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- SBT-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.